Home > Research Areas > Cancer > Chemotherapeutic Agents
Cat. No. Product name CAS No.
DCS-091 Cephalomannine

>98%,Standard References

71610-00-9
DCC-002 Vinblastine

>98%,Standard References

865-21-4
DCAPI1525 5-Azacytidine Featured

5-Azacytidine is a potent growth inhibitor and a cytotoxic agent. 5-Azacytidine acts as a demethylating agent by inhibiting DNA methyltransferase (Dnmt), forming covalent adducts with cellular DNMT1 depleting enzyme activity. 5-Azacytidine also improves t

320-67-2
DC8944 5-Fluorouracil

5-Fluorouracil is a potent antitumor agent that affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools.

51-21-8
DC11932 GPX-150

A doxorubicin analog that demonstrates anti-cancer activity without cardiotoxicity, does not inhibit topoisomerase IIβ activity at 100 uM.

236095-29-7
DC8923 AS-1413(Amonafide)

Amonafide(AS1413) produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage.

69408-81-7
DC9832 Betulinic acid Featured

Betulinic acid, a pentacyclic triterpene, selectively induces apoptosis in tumor cells, also is a inhibitor of HIV-1 with EC50 of 1.4 μ M.

472-15-1
DC4186 Cabazitaxel

Cabazitaxel (Jevtana, XRP6258) is a semi-synthetic derivative of a natural taxoid.

183133-96-2
DC9095 Carboplatin Featured

Carboplatin is a chemotherapy drug by binding to DNA and interfering with the cell's repair mechanism.

41575-94-4
DC2099 cis-Diaminedichloroplatinum Featured

Cisplatin is an inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.

15663-27-1
DC9013 Cyclophosphamide Featured

Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.

50-18-0
DC7069 Daunorubicin HCL Featured

Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.

23541-50-6
DCAPI1475 Dexrazoxane Hydrochloride

Dexrazoxane Hydrochloride

149003-01-0
DC11192 Elacytarabine

Elacytarabine (CP-4055, CP4055) is a fatty acid derivative of cytarabine with potential antineoplastic activity.

188181-42-2
DC5882 Fosbretabulin disodium Featured

Fosbretabulin disodium(CA 4DP; CA 4P) is a microtubule destabilizing drug, a type of vascular-targeting agent, a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.

168555-66-6
DC2108 Gemcitabine free base

Gemcitabine(Gemzar) belongs to the group of medicines called antimetabolites.

95058-81-4
DC8946 Gimeracil

Gimeracil(Gimestat) is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which degrades pyrimidine including 5-fluorouracil in the blood; inhibits homologous recombination.

103766-25-2
DC8111 Idarubicin Hydrochloride Featured

Idarubicin Hcl is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor.

57852-57-0
DC9014 Ifosfamide

Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.

3778-73-2
DC10406 Imisopasem manganese

Imisopasem manganese (M40403) is a stable non-peptidyl mimetic of manganese superoxide MnSOD.

218791-21-0
DC9050 Melphalan Featured

Melphalan(Sarcolysin; L-PAM) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents; attaches the alkyl group to the guanine base of DNA.

148-82-3
DC4182 Temozolomide Featured

Methazolastone (Temozolomide, Temodar, Temodal) is a DNA damage inducer.

85622-93-1
DC9298 thiotepa Featured

N,N’N’-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group.

52-24-4
DC7023 Ombrabulin Featured

Ombrabulin (AVE8062) hydrochloride is a synthetic derivative of CA-4-P, which inhibits growth in a large number of drug-resistant animal tumors and carcinogen-induced tumors.

181816-48-8
DC5885 Oxaliplatin Featured

Oxaliplatin is a second generation potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The development of Oxaliplatin was inspired from the eff

61825-94-3
DC8149 Pemetrexed disodium Featured

Pemetrexed disodium is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively.

150399-23-8
DC9359 Pralatrexate Featured

Pralatrexate(Folotyn) is an antifolate, and structurally a folate analog.

146464-95-1
DC8940 Raltitrexed Featured

Raltitrexed(ZD1694), an inhibitor of thymidylate synthase, is an antimetabolite drug used in cancer chemotherapy.

112887-68-0
DC7762 RX-3117 Featured

RX-3117 is an orally available and potent DNA synthesis inhibitor with potential antineoplastic activity.

865838-26-2
DC10444 Sapacitabine (CYC682) Featured

Sapacitabine is an orally bioavailable pyrimidine analogue prodrug with potential antineoplastic activity.

151823-14-2
DC6906 Aprepitant (MK-0869, L-754030) Featured

Substance P antagonists (SPA).

170729-80-3
DC8962 Tegafur Featured

Tegafur (also known as Ftorafur) is a chemotherapeutic 5-FU prodrug used in the treatment of cancers; is a component of tegafur-uracil.

17902-23-7
DC4184 Vinorelbine Ditartrate Featured

Vinorelbine (Navelbine) is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM.

125317-39-7
DC7530 Voreloxin Featured

Voreloxin(SNS-595; AG 7352) is a small molecule and a naphthyridine analogue with antineoplastic activity; inhibitor of Topo II.

175414-77-4
Page 1 / Total 1 FirstPrevNextLastGoto